| 1 |
IH-500 (Special & Extended Immunohematology) |
- Immunohematology screening for blood grouping discrepancy and Autoimmune Hemolytic Anemia (AIHA), multiple transfused alloimmune patients and any other IH workup as per requirement.
- Creation of rare red cell donor registry
|
| 2 |
Vitros-3600 (Chemiluminescence immunoassay (CLIA) assay) |
- For automated Screening for HBsAg, anti-HCV, anti-HIV and Syphilis
- CLIA have complementary advantages in blood screening, which can improve the sensitivity of blood screening, reduce the missed detection and shorten detection time.
- To achieve rapid turn around time (Random Access) especially for apheresis donor screening.
|
| 3 |
Nucleic Acid Test (NAT) TENDER UNDER PROCESS |
- Nucleic acid amplification test (NAT) technologies have the potential to detect viremia earlier than current screening methods, which are based on seroconversion.
- NAT is a molecular technique to detect viral nucleic acids of HIV 1-2, HBV, and HCV at a very low concentration in donor blood by Nucleic acid amplification technology.
|
| 4 |
Immucor Luminex (HLA TESTING) |
- HLA Testing for donor and recipient for organ transplantation, such as Renal, Liver and Bone Marrow Transplantation (BMT)
- HLA testing is utilized in the evaluation of a potential transplant recipient. Prior to transplantation, HLA typing is performed to assess donor/recipient mismatching, and anti-HLA antibody screening and cross matching are performed to evaluate the likelihood of rejection.
- This HLA platform is useful for the following tests:
- Low to intermediate resolution HLA A Typing by fluorescence sheath analyzer technology method
- Low to intermediate resolution HLA B Typing by fluorescence sheath analyzer technology method
- Low to intermediate resolution HLA C Typing by fluorescence sheath analyzer technology method
- Low to intermediate resolution DRB1 by fluorescence sheath analyzer technology method
- Low to intermediate resolution HLA DPA1/B1 by fluorescence sheath analyzer technology method
- KIR Typing by fluorescence sheath analyzer technology method
- C3D assay by fluorescence sheath analyzer technology method
- Mica assay by fluorescence sheath analyzer technology method
- Non-HLA antibody assay by fluorescence sheath analyzer technology method
- Donor specific antibody (DSA) assay (Donor lysate based cross match) by fluorescence sheath analyzer technology method
- Panel Reactive antibody (PRA) class-I by fluorescence sheath analyzer technology method
- Panel Reactive antibody (PRA) Class-II by fluorescence sheath analyzer technology method
- Single antigen bead assay class-I by fluorescence sheath analyzer technology method
- Single antigen bead assay class-II by fluorescence sheath analyzer technology method
- CDC Cross match
|
| 5 |
Illumina (HLA TESTING BY Next Generation Sequencer (NGS)) |
- The use of Next Generation Sequencing (NGS) to interrogate cell-free DNA (cfDNA) as a transplant diagnostic provides a crucial step in improving the accuracy of post-transplant monitoring of allograft health.
- Molecular blood typing and resolution of complex serological issues
|
| 6 |
ROTEM (Rotational thromboelastometry) |
Rotational thromboelastometry (ROTEM) testing to guide blood component therapy for polytrauma cases, Liver transplant procedures, Massive transfusion and postpartum hemorrhage (PPH) cases, etc. |
| 7 |
Coagulation Tests (ACL Pro Automatic Coagulation Analyzer) |
- Fully automated, high-productivity analyzers for in vitro diagnostic clinical use in the hemostasis laboratory for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis.
- Coagulation parameter for DIC cases – Identification of coagulation factor deficiencies such as Hemophilia A, B and other acquired coagulation disorders.
- Parameters:
- PT-INR / APTT
- Fibrinogen
- Factor VII assay
- Factor VIII assay
- Von Willebrand factor
- Protein C
- Protein S activity etc.
|
